Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001104659-16-118799
Filing Date
2016-05-06
Accepted
2016-05-06 16:57:41
Documents
3
Period of Report
2014-05-07

Document Format Files

Seq Description Document Type Size
1 4/A a4a.html 4/A  
1 4/A a4a.xml 4/A 4318
2 EX-24 ex-24.htm EX-24 15837
3 GRAPHIC g107884kii001.gif GRAPHIC 2679
  Complete submission text file 0001104659-16-118799.txt   25282
Mailing Address 64 SIDNEY ST. CAMBRIDGE MA 02139
Business Address 64 SIDNEY ST. CAMBRIDGE MA 02139 7349305555
Vericel Corp (Issuer) CIK: 0000887359 (see all company filings)

EIN.: 943096597 | State of Incorp.: MI | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address
Business Address
ZERBE ROBERT L MD (Reporting) CIK: 0001220363 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-35280 | Film No.: 161628940